LYEL · Lyell Immunopharma, Inc.

Summary

Lyell Immunopharma, Inc. furnished its press release dated March 12, 2026, under Item 2.02 regarding results of operations via Exhibit 99.1. This disclosure provides key financial information relevant to investors.

Key takeaways

• Form 8-K filed on 2026-03-12
• Item 2.02 - Results of Operations
• Exhibit 99.1 - Press Release dated 2026-03-12